Working… Menu

Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03298022
Recruitment Status : Completed
First Posted : September 29, 2017
Last Update Posted : August 17, 2020
Information provided by (Responsible Party):
AltruBio Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : April 6, 2020
Actual Study Completion Date : June 1, 2020